Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on Emerson’s leading software and solutions portfolio and life sciences expertise. Emerson made an equity investment in Fluxa, which is based in Glendale, California, in 2021. Fluxa accelerates the speed to market for new therapies by helping drug development and manufacturing organizations harness the power of collaboration and data across sites, functions and processes. The acquisition of Fluxa’s PKM™ software will provide customers a unique sol(…) Read More »